Felodipine Tablet, Film Coated
Product Images NDC 61442-433

6 FDA label images from Carlsbad Technology, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 61442-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carlsbad Technology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (1 Formula)

Image Description (1 Formula)
Chemical structure diagram of Felodipine, illustrating its molecular arrangement with labeled atoms and bonds.*
FDA Label Image

Image Description (10mg 500ct Label)

Image Description (10mg 500ct Label)
Label for Felodipine Extended-Release Tablets, USP 10 mg by Carlsbad Technology, Inc. The label indicates the package contains 500 tablets. It includes dosage instructions, storage conditions, and dispensing information, highlighting the extended-release formulation and oral tablet dosage form.*
FDA Label Image

Image Description (2.5mg 500ct Label)

Image Description (2.5mg 500ct Label)
Felodipine Extended-Release Tablets USP 2.5 mg film-coated tablets in a package label showing 500 tablets. Labeler is Carlsbad Technology, Inc. The label states each extended-release tablet contains 2.5 mg felodipine and includes storage instructions and handling precautions.*
FDA Label Image

Image Description (5mg 500ct Label)

Image Description (5mg 500ct Label)
Label for Felodipine Extended-Release Tablets USP, 5 mg, by Carlsbad Technology, Inc. The label indicates the product is prescription only (Rx only) and contains 500 tablets. Directions on proper storage and handling are included, as well as a barcode and manufacturing information.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A table labeled "Mean Reductions in Blood Pressure (mmHg)" presenting data from two studies on the effects of different Felodipine doses. It shows doses, sample sizes, systolic/diastolic mean peak response, mean trough response, and trough/peak ratios, with notes on placebo subtraction and patient counts for measurements.*
FDA Label Image

Table 2 (Table 2)

Table 2 (Table 2)
Table presenting the percent of patients experiencing adverse events in controlled trials of Felodipine extended-release tablets at doses of 2.5 mg, 5 mg, and 10 mg compared to placebo. The table categorizes events by body system and lists incidence rates alongside discontinuation rates in parentheses for each dosage group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.